Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Cash & Current Investments (2019 - 2025)

Vivos Therapeutics has reported Cash & Current Investments over the past 7 years, most recently at $2.0 million for Q4 2025.

  • Quarterly Cash & Current Investments fell 67.59% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 67.59% year-over-year, with the annual reading at $2.0 million for FY2025, 67.59% down from the prior year.
  • Cash & Current Investments was $2.0 million for Q4 2025 at Vivos Therapeutics, down from $3.1 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $34.2 million in Q2 2021 and troughed at $1.0 million in Q3 2023.
  • The 5-year median for Cash & Current Investments is $6.3 million (2024), against an average of $9.5 million.
  • Year-over-year, Cash & Current Investments plummeted 85.34% in 2022 and then skyrocketed 531.1% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $24.0 million in 2021, then plummeted by 85.34% to $3.5 million in 2022, then tumbled by 53.31% to $1.6 million in 2023, then surged by 281.01% to $6.3 million in 2024, then tumbled by 67.59% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Cash & Current Investments are $2.0 million (Q4 2025), $3.1 million (Q3 2025), and $4.4 million (Q2 2025).